LDN and Multiple Sclerosis (MS)
There is a lot of talk in the MS community about LDN treatment.
The theory is that when endorphins are blocked the body compensates by creating more.
Hearing the Voice of MS
There is a lot of talk in the MS community about LDN treatment.
The theory is that when endorphins are blocked the body compensates by creating more.
Researchers found that people with multiple sclerosis using a foot stimulator increased walking performance, compared to the exercise group and also experienced fewer falls.
If we knew early on what the disease course for Multiple Sclerosis would be then we could better target the medication in each individual case.
Hello again. Thanls for calling back. REMEMBER to share any post you like. Just click share and you can choose where to share it OR if you have a twitter account just “Tweet This” at the end of the post.. Thanks for visiting! —————————–> Well that’s a bit of a scary phrase. Introduction Vascular co-morbidity [...]
Although the exact cause of multiple sclerosis (MS) is unknown, a number of genetic and environmental factors are thought to influence MS susceptibility. Fortunately there is an animal model of MS called experimental autoimmune encephalomyelitis or EAE which allows us to investigate possible treatment for MS. and so it was with this model that the [...]
Two people experienced serious side effects following stenting of the jugular veins, One patient died from a brain haemorrhage. Another required emergency open heart surgery The article on the MS Society site can be seen here
Interferon beta (IFNb) is a first-line treatment for people with MS. However, increasing evidence suggests that the presence of neutralising antibodies during treatment is associated with a reduction in treatment efficacy
The results of the study, reported in the Sunday Times Scotland, suggest that mothers pregnant during the dark autumn and winter months were most likely to give birth to those who would develop MS
It has been recently shown that MS is significantly associated with a condition defined as chronic cerebrospinal venous insufficiency (CCSVI). In CCSVI, put simply, there is a narrowing of the vessels draining blood away from the brain.Blocked venous blood outflow causes a high rate of cerebral venous reflux in MS patients.
As a follow on from my previous article about spasticity I would now like to address the treatments used